Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Albemarle has upgraded and expanded its FDA-registered South Haven, Michigan site to increase capabilities and production.
Subscribe to our email newsletter
Production using the new expanded capacity at its multi-product cGMP active pharmaceutical ingredient (API) manufacturing facility commenced on 1 June 2012.
The investment matches the solids handling equipment with the reactor capacity and is expected to allow the company to advance its portfolio of custom API products, several of which have progressed to late stage clinical development and pre-registration status.
Albemarle uses the Quality by Design approach to establish manufacturing processes and then speed validated commercial products to market, according to the company.